670 related articles for article (PubMed ID: 14517554)
1. Keap1-null mutation leads to postnatal lethality due to constitutive Nrf2 activation.
Wakabayashi N; Itoh K; Wakabayashi J; Motohashi H; Noda S; Takahashi S; Imakado S; Kotsuji T; Otsuka F; Roop DR; Harada T; Engel JD; Yamamoto M
Nat Genet; 2003 Nov; 35(3):238-45. PubMed ID: 14517554
[TBL] [Abstract][Full Text] [Related]
2. Nrf2-Keap1 defines a physiologically important stress response mechanism.
Motohashi H; Yamamoto M
Trends Mol Med; 2004 Nov; 10(11):549-57. PubMed ID: 15519281
[TBL] [Abstract][Full Text] [Related]
3. Small Maf proteins serve as transcriptional cofactors for keratinocyte differentiation in the Keap1-Nrf2 regulatory pathway.
Motohashi H; Katsuoka F; Engel JD; Yamamoto M
Proc Natl Acad Sci U S A; 2004 Apr; 101(17):6379-84. PubMed ID: 15087497
[TBL] [Abstract][Full Text] [Related]
4. Keap1 regulates the oxidation-sensitive shuttling of Nrf2 into and out of the nucleus via a Crm1-dependent nuclear export mechanism.
Velichkova M; Hasson T
Mol Cell Biol; 2005 Jun; 25(11):4501-13. PubMed ID: 15899855
[TBL] [Abstract][Full Text] [Related]
5. The Keap1-BTB protein is an adaptor that bridges Nrf2 to a Cul3-based E3 ligase: oxidative stress sensing by a Cul3-Keap1 ligase.
Cullinan SB; Gordan JD; Jin J; Harper JW; Diehl JA
Mol Cell Biol; 2004 Oct; 24(19):8477-86. PubMed ID: 15367669
[TBL] [Abstract][Full Text] [Related]
6. Molecular mechanism activating Nrf2-Keap1 pathway in regulation of adaptive response to electrophiles.
Itoh K; Tong KI; Yamamoto M
Free Radic Biol Med; 2004 May; 36(10):1208-13. PubMed ID: 15110385
[TBL] [Abstract][Full Text] [Related]
7. Unique function of the Nrf2-Keap1 pathway in the inducible expression of antioxidant and detoxifying enzymes.
Kobayashi A; Ohta T; Yamamoto M
Methods Enzymol; 2004; 378():273-86. PubMed ID: 15038975
[No Abstract] [Full Text] [Related]
8. Scaffolding of Keap1 to the actin cytoskeleton controls the function of Nrf2 as key regulator of cytoprotective phase 2 genes.
Kang MI; Kobayashi A; Wakabayashi N; Kim SG; Yamamoto M
Proc Natl Acad Sci U S A; 2004 Feb; 101(7):2046-51. PubMed ID: 14764898
[TBL] [Abstract][Full Text] [Related]
9. Evolutionary conserved N-terminal domain of Nrf2 is essential for the Keap1-mediated degradation of the protein by proteasome.
Katoh Y; Iida K; Kang MI; Kobayashi A; Mizukami M; Tong KI; McMahon M; Hayes JD; Itoh K; Yamamoto M
Arch Biochem Biophys; 2005 Jan; 433(2):342-50. PubMed ID: 15581590
[TBL] [Abstract][Full Text] [Related]
10. Chemoprevention through the Keap1-Nrf2 signaling pathway by phase 2 enzyme inducers.
Kwak MK; Wakabayashi N; Kensler TW
Mutat Res; 2004 Nov; 555(1-2):133-48. PubMed ID: 15476857
[TBL] [Abstract][Full Text] [Related]
11. Keap1 regulates both cytoplasmic-nuclear shuttling and degradation of Nrf2 in response to electrophiles.
Itoh K; Wakabayashi N; Katoh Y; Ishii T; O'Connor T; Yamamoto M
Genes Cells; 2003 Apr; 8(4):379-91. PubMed ID: 12653965
[TBL] [Abstract][Full Text] [Related]
12. Direct evidence that sulfhydryl groups of Keap1 are the sensors regulating induction of phase 2 enzymes that protect against carcinogens and oxidants.
Dinkova-Kostova AT; Holtzclaw WD; Cole RN; Itoh K; Wakabayashi N; Katoh Y; Yamamoto M; Talalay P
Proc Natl Acad Sci U S A; 2002 Sep; 99(18):11908-13. PubMed ID: 12193649
[TBL] [Abstract][Full Text] [Related]
13. Modulation of gene expression by cancer chemopreventive dithiolethiones through the Keap1-Nrf2 pathway. Identification of novel gene clusters for cell survival.
Kwak MK; Wakabayashi N; Itoh K; Motohashi H; Yamamoto M; Kensler TW
J Biol Chem; 2003 Mar; 278(10):8135-45. PubMed ID: 12506115
[TBL] [Abstract][Full Text] [Related]
14. The Keap1 BTB/POZ dimerization function is required to sequester Nrf2 in cytoplasm.
Zipper LM; Mulcahy RT
J Biol Chem; 2002 Sep; 277(39):36544-52. PubMed ID: 12145307
[TBL] [Abstract][Full Text] [Related]
15. Identification of the interactive interface and phylogenic conservation of the Nrf2-Keap1 system.
Kobayashi M; Itoh K; Suzuki T; Osanai H; Nishikawa K; Katoh Y; Takagi Y; Yamamoto M
Genes Cells; 2002 Aug; 7(8):807-20. PubMed ID: 12167159
[TBL] [Abstract][Full Text] [Related]
16. Ultraviolet A irradiation induces NF-E2-related factor 2 activation in dermal fibroblasts: protective role in UVA-induced apoptosis.
Hirota A; Kawachi Y; Itoh K; Nakamura Y; Xu X; Banno T; Takahashi T; Yamamoto M; Otsuka F
J Invest Dermatol; 2005 Apr; 124(4):825-32. PubMed ID: 15816842
[TBL] [Abstract][Full Text] [Related]
17. Select heterozygous Keap1 mutations have a dominant-negative effect on wild-type Keap1 in vivo.
Suzuki T; Maher J; Yamamoto M
Cancer Res; 2011 Mar; 71(5):1700-9. PubMed ID: 21177379
[TBL] [Abstract][Full Text] [Related]
18. Distinct cysteine residues in Keap1 are required for Keap1-dependent ubiquitination of Nrf2 and for stabilization of Nrf2 by chemopreventive agents and oxidative stress.
Zhang DD; Hannink M
Mol Cell Biol; 2003 Nov; 23(22):8137-51. PubMed ID: 14585973
[TBL] [Abstract][Full Text] [Related]
19. Genetic analysis of cytoprotective functions supported by graded expression of Keap1.
Taguchi K; Maher JM; Suzuki T; Kawatani Y; Motohashi H; Yamamoto M
Mol Cell Biol; 2010 Jun; 30(12):3016-26. PubMed ID: 20404090
[TBL] [Abstract][Full Text] [Related]
20. Protection against electrophile and oxidant stress by induction of the phase 2 response: fate of cysteines of the Keap1 sensor modified by inducers.
Wakabayashi N; Dinkova-Kostova AT; Holtzclaw WD; Kang MI; Kobayashi A; Yamamoto M; Kensler TW; Talalay P
Proc Natl Acad Sci U S A; 2004 Feb; 101(7):2040-5. PubMed ID: 14764894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
